Two More Drug Companies Join TrumpRx Discount Program

Abbvie and Genentech to sell popular medications at reduced prices on White House's pharmaceutical site

Apr. 6, 2026 at 10:03pm

Got story updates? Submit your updates here. ›

A minimalist neon outline of a medical pill capsule, its shape defined by glowing, vibrant lines of green, blue, and pink against a dark background, conceptually representing the discounted prescription drug program.The TrumpRx program aims to make popular prescription drugs more affordable for uninsured Americans through deals with major pharmaceutical companies.Washington Today

Two major pharmaceutical companies, Abbvie and Genentech, will begin selling popular prescription drugs on the White House's discounted TrumpRx website as soon as Monday. Abbvie will offer its rheumatoid arthritis, Crohn's, and ulcerative colitis medication Humira at an 86% discount, while Genentech will sell its flu treatment Xofluza at around $50, down from $168. The TrumpRx program now features over 61 drugs at lower prices for uninsured patients.

Why it matters

The addition of Abbvie and Genentech to the TrumpRx program represents the White House's ongoing efforts to lower prescription drug costs for uninsured Americans through negotiated deals with pharmaceutical companies. This initiative aims to make critical medications more affordable and accessible for those who lack insurance coverage.

The details

Under the deals, Abbvie will sell its Humira Pen (adalimumab) on TrumpRx at a discounted price of $950, down from the typical uninsured cost of over $6,900. Genentech will offer its flu treatment Xofluza for around $50, a significant reduction from the original $168 price tag. Additionally, Amgen will expand its TrumpRx offerings to include the arthritis drug Enbrel and the plaque psoriasis medication Otezla.

  • The new Abbvie and Genentech offerings will launch on the TrumpRx website as soon as Monday, April 8, 2026.
  • The TrumpRx program first went live in February 2026 with around 40 drug offerings, and has since expanded to over 61 medications.

The players

Abbvie

A major American pharmaceutical company that manufactures the rheumatoid arthritis, Crohn's, and ulcerative colitis medication Humira.

Genentech

A biotechnology company and subsidiary of Roche that produces the flu treatment medication Xofluza.

Amgen

A multinational biopharmaceutical company that will expand its offerings on TrumpRx to include the arthritis drug Enbrel and the plaque psoriasis medication Otezla.

TrumpRx

A White House-backed website that features discounted prescription drugs from pharmaceutical companies, aimed at making medications more affordable for uninsured Americans.

Got photos? Submit your photos here. ›

What’s next

The White House is expected to continue negotiating with additional pharmaceutical companies to expand the TrumpRx program and offer more discounted medications to uninsured patients.

The takeaway

The TrumpRx initiative demonstrates the government's commitment to making critical prescription drugs more affordable and accessible for Americans who lack health insurance coverage, though the program's long-term impact and sustainability remain to be seen.